Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Klibanski

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1996
Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center studyH B Baum, B M Biller, L Katznelson, et al.
Annals of Internal Medicine|November 1, 1992
Octreotide treatment of acromegaly. A randomized, multicenter studyS Ezzat, P J Snyder, W F Young, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomasL Katznelson, J S Bogan, J R Trob, et al.
International Journal of Radiation Oncology, Biology, Physics|March 10, 2001
Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysisH H Pai, A Thornton, L Katznelson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1995
Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center studyC B Newman, S Melmed, P J Snyder, et al.
Clinical Endocrinology|February 24, 2001
Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot studyL Katznelson, D Kleinberg, M L Vance, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Octreotide as primary therapy for acromegalyC B Newman, S Melmed, A George, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statementB M K Biller, A B Grossman, P M Stewart, et al.
Lancet (London, England)|December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1996
Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center studyH B Baum, B M Biller, L Katznelson, et al.
Annals of Internal Medicine|November 1, 1992
Octreotide treatment of acromegaly. A randomized, multicenter studyS Ezzat, P J Snyder, W F Young, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomasL Katznelson, J S Bogan, J R Trob, et al.
International Journal of Radiation Oncology, Biology, Physics|March 10, 2001
Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysisH H Pai, A Thornton, L Katznelson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1995
Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center studyC B Newman, S Melmed, P J Snyder, et al.
Clinical Endocrinology|February 24, 2001
Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot studyL Katznelson, D Kleinberg, M L Vance, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Octreotide as primary therapy for acromegalyC B Newman, S Melmed, A George, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statementB M K Biller, A B Grossman, P M Stewart, et al.
Lancet (London, England)|December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
Pageof 17